3 February 2021 in Phytotherapy Research
9 March 2021 in Journal of Obesity
Objective. This review investigated the effects and safety of Chinese herbal medicine (CHM) formulas on weight management. Methods. Eighteen databases in English, Chinese, Korean, and Japanese were searched from their inceptions to September 2019. The treatment groups included CHM formulations, and the control included placebo, Western medication (WM), and lifestyle intervention (LI), with or without cointerventions (WM and/or LI). Quality of studies was assessed using Cochrane Collaborations risk of bias assessment tool. Body weight and body mass index (BMI) were analysed in RevMan v5.4.1 and expressed as mean differences with 95 confidence intervals (CI), while adverse events were expressed as risk ratio with 95 CI. Results. Thirty-nine RCTs were eligible for qualitative analysis, 34 of which were included in the meta-analyses. The majority of studies had a high or unclear risk of selection, performance, and detection bias. Twenty-five CHM studies involving cointerventions revealed that CHM had significant adjunct effects on body weight and BMI at the end of treatment compared to control. No serious adverse events were reported in the CHM groups. Conclusion. CHM indicates a promising adjunct to facilitate WM or lifestyle change for weight management. However, methodological barriers such as lack of allocation concealment and double-blinding may have led to challenges in data synthesis. More rigorously designed RCTs involving cointerventions are warranted.
17 September 2023 in Computers in Biology and Medicine
The lotus leaf, Nelumbinis folium (NF), has frequently appeared in obesity clinical trials as an intervention to promote weight loss and improve metabolic profiles. However, the molecular mechanisms by which it interacts with important obesity targets and pathways, such as the peroxisome proliferator-activated receptor gamma (PPARγ) within the PPAR signalling pathway, were not well understood. This study aims to screen for candidate compounds from NF with desirable pharmacokinetic properties and examine their binding feasibility at the PPARγ ligand-binding domain (LBD). Ligand- and structure-based screening of NF compounds were performed, and a consensus approach has been applied to identify druggable candidates. By examining the pharmacokinetic profiles, a large proportion of NF compounds exhibited favourable drug-likeness and oral bioavailability properties. Furthermore, the binding affinity scores and poses provided new insights on the distinctive binding behaviours of NF compounds at the LBD of PPARγ in its inactive form. Several NF compounds could bind strongly to PPARγ at sub-pockets where partial agonists and antagonists were found to bind and may induce conformational changes that influence co-repressor binding, trans-repression, and gene expression inhibition. Subsequent molecular dynamics simulations of a candidate compound (NF129 narcissin) bound to PPARγ revealed conformational stability, residue fluctuation, and binding behaviours comparable to that of the known inhibitor, SR1664. Therefore, it can be proposed that narcissin exhibits characteristics of a PPARγ antagonist. Further experimental validation to support the development of NF129 as a future anti-obesity agent is warranted.
24 September 2026 in SLAS Discovery
Macrophages play central roles in tissue repair and remodelling, host defence and immunopathology. Their ability to rapidly reprogram key functions in response to local cues makes them attractive targets for drug discovery. While this plasticity creates therapeutic opportunities, it also complicates high-throughput screening since multiple, transient functional states can coexist. To address this challenge, we developed a 384-well, single-cell pipeline that uses two well-established biomarkers, inducible nitric oxide synthase and Arginase 1, as a compact primary readout for macrophage state. We benchmarked this targeted approach against untargeted image-based profiling, Cell Painting and ChromaLIVE. In a pilot screen, the biomarker panel rapidly identified distinct, biologically relevant hit classes. The paint approaches provided complementary, high-dimensional information useful for resolving ambiguous calls, though at increased computational cost. A probe-first, paint-second workflow optimally balances throughput, biological interpretability and computational efficiency, enabling scalable discovery of macrophage modulators.